Brind.

Vertex Pharmaceuticals acquired Alpine Immune Sciences, which markets Symkevi in Europe.

1 report, 1 independent Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Vertex Pharmaceuticals acquired Alpine Immune Sciences, which markets Symkevi in Europe.

Who's involved

What this event is mainly about
Vertex PharmaceuticalsAlpine Immune Sciences

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksWhy Is Vertex (VRTX) Up 6.9% Since Last Earnings Report? A month has gone by since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 6.9% in that time frame, outperf